ProfileGDS5822 / ILMN_2988678
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 82% 78% 74% 81% 76% 82% 83% 80% 82% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1168.982
GSM1276600PDAC Late Ablation Control 2115.878
GSM1276601PDAC Late Ablation Control 3110.274
GSM1276602PDAC Late Ablation 1161.881
GSM1276603PDAC Late Ablation 2103.276
GSM1276604PDAC Late Ablation 3203.482
GSM1303940PDAC Late Ablation_anti-CTLA4 1189.283
GSM1303941PDAC Late Ablation_anti-CTLA4 2176.280
GSM1303942PDAC Late Ablation_anti-CTLA4 3223.182